Unlock instant, AI-driven research and patent intelligence for your innovation.

Flurbiprofen axetil crystal and preparation method thereof

A flurbiprofen axetil and crystal form technology, which is applied in a crystal form of flurbiprofen axetil and its preparation field, can solve the problems of cumbersome steps and high cost

Inactive Publication Date: 2021-07-27
SHANGHAI ZHONGXI SUNVE PHARMA
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these methods can remove impurities, the cost is too high and the steps are cumbersome, so it is urgent to develop new refining methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Flurbiprofen axetil crystal and preparation method thereof
  • Flurbiprofen axetil crystal and preparation method thereof
  • Flurbiprofen axetil crystal and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0074] The preparation method of flurbiprofen axetil crystal form I

[0075] The present invention also provides a method for preparing flurbiprofen axetil crystal form I as described herein, specifically, the method includes:

[0076] 1. Miscible flurbiprofen axetil melt or crystals of any crystal form with a solvent.

[0077] In this step, the solvent is preferably methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, sec-butanol, acetone, acetonitrile, tetrahydrofuran, water or a mixture thereof, more preferably methanol , isopropanol and acetone. The volume of the added organic solvent is 2 to 8 times the mass of flurbiprofen axetil.

[0078] 2. Add the seed crystals of flurbiprofen axetil to the above solution.

[0079] Wherein, the mass of the added seed crystal is preferably 0.1%-5% of the mass of flurbiprofen axetil, more preferably 0.5-2%. The seed crystal can be the ground product of flurbiprofen axetil solidified at low temperature, or the crystal o...

Embodiment 1

[0100] Charge 30g flurbiprofen axetil melt and 60mL methanol into the reactor, stir and miscible, and the solution is clear now. Add 0.3 g of flurbiprofen axetil crystal form I as a seed crystal. Stir at constant temperature at 10°C for 4h, and crystallize. Suction filter with a Buchner funnel, wash the filter cake three times with water, and freeze-dry the washed filter cake. 24g of flurbiprofen axetil crystal form I was obtained with a yield of 80% and a melting point of 35±3°C.

[0101] The obtained product is a solid white powder, and its DSC spectrum is as follows: figure 1 Shown in, result shows, this solid powder has obvious melting point in DSC collection of illustrative plates, and existing flurbiprofen axetil is colorless transparent oily liquid, prompts that the solid white powder that is prepared is crystalline form.

[0102] The obtained flurbiprofen axetil crystal form I is subjected to a powder X-ray diffraction test, and the results are as follows: figure ...

Embodiment 2

[0113] 30g of flurbiprofen axetil melt, 60mL of methanol and 180mL of purified water were charged into the reactor, stirred and miscible, and the solution was in the form of an emulsion at this time. 1.5 g of flurbiprofen axetil crystal form I was added as a seed crystal. Stir at constant temperature at 20°C for 8h to crystallize. Suction filter with a Buchner funnel, wash the filter cake three times with water, and freeze-dry the washed filter cake. 28 g of flurbiprofen axetil crystal form I was obtained with a yield of 93.3% and a melting point of 35±3°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention provides a flurbiprofen axetil crystal and a preparation method thereof, and particularly provides a flurbiprofen axetil crystal form I. The flurbiprofen axetil crystal form I is characterized in that the flurbiprofen axetil crystal form I has characteristic peaks at the positions of 14.2 degrees + / -0.2 degrees, 16.3 degrees + / -0.2 degrees, 16.6 degrees + / -0.2 degrees, 17.5 degrees + / -0.2 degrees, 18.1 degrees + / -0.2 degrees, 21.8 degrees + / -0.2 degrees, 22.3 degrees + / -0.2 degrees, 23.9 degrees + / -0.2 degrees, 25.6 degrees + / -0.2 degrees and 26.3 degrees + / -0.2 degrees when diffracted by X-ray diffraction powder. The invention also discloses a preparation method of the flurbiprofen axetil crystal. The preparation method is simple, and has potential development and application values in the fields of industrial manufacturing and pharmaceutical preparations of flurbiprofen axetil.

Description

technical field [0001] The present invention relates to a crystal form of flurbiprofen axetil and a preparation method thereof, in particular to a crystal form I of flurbiprofen axetil and a preparation method thereof. Background technique [0002] Flurbiprofen axetil is a prodrug of flurbiprofen, used for analgesia after surgery and various cancers. It reduces the hyperalgesic state caused by surgical trauma by inhibiting cyclooxygenase (COX) in the spinal cord and the periphery to reduce the synthesis of prostaglandins. The common dosage forms are injection and lipid microspheres. Lipomicrosphere preparations have stronger drug effects, faster onset and longer duration, and are less likely to cause adverse reactions such as gastric mucosal damage. Compared with other analgesic drugs, the advantage of flurbiprofen axetil is that it has no central inhibitory effect, does not affect the recovery of patients under anesthesia, and can be used immediately after surgery. [00...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C69/65C07C67/52A61K31/216A61P29/00
CPCC07C69/65C07C67/52A61P29/00C07B2200/13
Inventor 颜国明李璐尹超杨猛衷盛陈颖源
Owner SHANGHAI ZHONGXI SUNVE PHARMA